PharmGKB Blog
Friday, May 27, 2016

NIGMS Request for Information: Approaches for Supporting Team Science in the Biomedical Research Community

›
The National Institute of General Medical Sciences (NIGMS) has issued a request for information (RFI: Approaches for Supporting Team Scienc...
Thursday, May 26, 2016

Race and Pharmacogenetics discussed in the New England Journal of Medicine

›
The authors of a new Perspective in the New England Journal of Medicine ( “Will precision medicine move us beyond race?” ) focus on the pot...
Thursday, May 19, 2016

Pharmacogenetics in Scientific American

›
Dina Fine Maron discusses pharmacogenetics and pharmacogenomics (PGx) in a new video and article titled “A Very Personal Problem” in this...
Wednesday, May 11, 2016

European Union awards €15 million to U-PGx consortium

›
The European Union H2020 programme has awarded a €15 million grant to the Ubiquitous Pharmacogenomics (U-PGx) consortium for an internation...
Tuesday, May 10, 2016

Evidence of pharmacogenetics in aiding polypharmacy outcomes

›
Many drugs interact with the same enzymes and transporters. As a result, variation in the genes encoding these proteins can affect risks of ...
Wednesday, April 20, 2016

Introducing the new PharmGKB Cancer PGx Portal

›
PharmGKB has collected a number of resources for Cancer PGx into one easy location . There are tables with direct links to genes imp...
Tuesday, April 19, 2016

Top 100 Prescribed Drugs with CPIC Guidelines

›
Pharmacogenetics has important consequences for some of the most commonly prescribed medications. Depending on the source and structure of t...
‹
›
Home
View web version

Contributors

  • Caroline Thorn, Curator
  • Katrin Sangkuhl
  • Li Gong
  • Mark Woon
  • Mark Woon
  • Michelle Whirl-Carrillo, Director and Co-PI
  • Ryan Whaley, Technical Lead
  • Teri Klein, Co-PI PharmGKB, CPIC, PharmCAT & ClinGen
Powered by Blogger.